Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details)

v3.24.1.1.u2
SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Segment Reporting Information [Line Items]    
Net revenue $ 25,962 $ 30,001
Direct operating costs 15,177 18,107
Selling and marketing 1,770 2,612
General and administrative 3,721 5,120
Research and development 913 1,078
Depreciation and amortization 3,930 3,038
Net loss on lease terminations, unoccupied lease charges and restructuring costs 322 269
Total operating expenses 25,833 30,224
OPERATING INCOME (LOSS) 129 (223)
Healthcare IT [Member]    
Segment Reporting Information [Line Items]    
Net revenue 22,721 26,954
Direct operating costs 12,544 15,693
Selling and marketing 1,760 2,604
General and administrative 2,581 2,496
Research and development 913 1,078
Depreciation and amortization 3,845 2,949
Net loss on lease terminations, unoccupied lease charges and restructuring costs 322 269
Total operating expenses 21,965 25,089
OPERATING INCOME (LOSS) 756 1,865
Medical Practice Management [Member]    
Segment Reporting Information [Line Items]    
Net revenue 3,241 3,047
Direct operating costs 2,633 2,414
Selling and marketing 10 8
General and administrative 434 448
Research and development
Depreciation and amortization 85 89
Net loss on lease terminations, unoccupied lease charges and restructuring costs
Total operating expenses 3,162 2,959
OPERATING INCOME (LOSS) 79 88
Unallocated Corporate Expenses [Member]    
Segment Reporting Information [Line Items]    
Net revenue
Direct operating costs
Selling and marketing
General and administrative 706 2,176
Research and development
Depreciation and amortization
Net loss on lease terminations, unoccupied lease charges and restructuring costs
Total operating expenses 706 2,176
OPERATING INCOME (LOSS) $ (706) $ (2,176)